IPCI (MCAP $39 M) = AWAITING 8 FDA APPROVALS WITHIN 1 YEAR // FIRST APPROVAL THIS MONTH
A REAL LIFETIME OPPORTUNITY HERE FOLKS .....
IPCI IS THE BEST AND THE MOST UNDERVALUED UNKNOWN GEM IN THE BIOTECH SECTOR BUT PLEASE DO YOUR OWN RESEARCH ! GLTA
This Unknown ULTRA LOW FLOAT Stock awaiting 8 FDA approvals.IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including two potential Blockbuster .
6x FDA APPROVALS WITHIN NEXT 12 MONTHS = $15++ EASILY FOLKS !!!
Market Cap:$ 39 M
Shares Out: 17.7 Mil..(10 Mil Shares held by Insiders/Institutions)
SUPER LOW FLOAT: 6 M
Intellipharmaceutics has now announced eight ANDAs as having been filed with the FDA, with reported sales by others for branded and generic versions of these products being approximately $4.5 billion for the 12 months ended July 2012. The Company develops both ANDA product candidates and new drugs through the New Drug Application (NDA) 505(b)(2) regulatory pathway. There can be no assurance as to whether or when the FDA will approve any Intellipharmaceutics' application.